Fig. 4
From: Sialyl-Tn serves as a potential therapeutic target for ovarian cancer
Box and whisker plots displaying distribution of serum STn levels (log concentration scaled left axis, log (concentration) right axis) by stage for clear cell OvCa with significant difference between early stage (I & II) and late stage (III & IV) p = 0.002 (panel A), mucinous ovarian cancer (panel B), endometrioid OvCa (panel C), and serous OvCa (panel D). Serum STn versus serum CA125 bivariate plot coded by histology (serous (red), mucinous (orange), endometrioid (green), clear cell (blue), benign (purple) panel E)